On March 1, in the Hong Kong stock market, Beishui traded a net purchase of 1.879 billion, of which Hong Kong stock connect (Shanghai) traded a net purchase of HK $2.215 billion and Hong Kong stock connect (Shenzhen) traded a net purchase of HK $336 million.
The stocks that beishuijing bought most were Tencent (00700), Yaoming Biology (02269) and CNOOC (00883). The largest number of shares sold by beishuijing are Great Wall Motor Company Limited(601633) (02333), HKEx (00388) and Tsingtao Brewery Company Limited(600600) shares (00168).
Top 10 active trading stocks of Hong Kong stock connect (Shanghai)
Top 10 active trading stocks of Hong Kong stock connect (Shenzhen)
Tencent (00700) received a net purchase of HK $1.391 billion. On the news side, Guosen Securities Co.Ltd(002736) released a research report that the regulatory direction of the Internet industry has not changed, but the margin has improved. We have the same view on the performance of the Internet industry throughout the year. With the relaxation of policy margin and improvement of performance, the sector is expected to rebound. In March, the Internet industry will release Kwai Chung annual report in 2021. We suggest that we should give priority to the layout of the Internet leading companies with excellent annual reports and NetEase. At the same time, Tencent's valuation has been at an all-time low -, which is a core asset with many high-quality upward options. It is suggested to bargain hunting layout.
Yaoming Biology (02269) received a net purchase of HK $227 million. On the news, Soochow Securities Co.Ltd(601555) said that due to the influence of market factors outside China and industrial policy factors, China's biotech share price has experienced a 50-60% correction since the second half of 2021. Considering the continuous optimization of the overseas pattern of domestic innovative drugs and the long-term policy to encourage innovation and development, at a time when the innovative drug environment has not changed greatly, High quality biotech company has entered the value range, which is the best time point for strategic layout of innovative drugs.
CNOOC (00883) received a net purchase of HK $185 million. On the news front, Cinda securities released a research report saying that maintaining CNOOC's "buy" rating benefited from rising crude oil prices and output growth. The performance growth accelerated from 2021 to 23, the valuation was at the absolute bottom of history, significantly lower than the industry level, and enjoyed high dividends. In view of the intensification of the shortage of crude oil supply and the production increase of OPEC + oil producing countries did not meet expectations, the Biden government has limited support for shale oil and raised the oil price and profit forecast.
China Power (02380) received a net purchase of HK $62.66 million. In terms of news, BOCOM international development research report pointed out that the national development and Reform Commission set the reasonable price range of 5500 kcal thermal coal in Qinhuangdao as 570770 yuan / ton, with the upper limit 10% lower than the previous proposal. At the same time, the national development and Reform Commission has made new pricing guidance for the main production bases of thermal coal, which will be implemented from May 2022. The bank said that China's power is still the first choice in the power industry.
Kingsley Biotechnology (01548) received a net purchase of HK $19.69 million. On the news surface, Kingsley biotechnology announced that the legendary xidakiolensai local time on February 28, the US listing application (BLA) was approved by FDA for the treatment of adult recurrent / refractory multiple myeloma (mm), becoming China's first FDA approved cell therapy product and the world's second approved car-t cell immunotherapy targeting BCMA.
Shunyu optics (02382) was sold net of HK $28.82 million. On the news side, UBS maintained the "neutral" rating of Shunyu optical technology, and the target price was reduced by 13% from HK $230 to HK $200. The bank said that the downward trend based on the specification of mobile phone lens is expected to continue in the first half of this year; The shortage of parts is limiting the growth of automobile lens, and the excessive expectation of this year's growth will lead to further profit reduction and other adverse factors in the market. Therefore, we maintain a cautious attitude towards the prospect of the industry. In addition, Damo rated Shunyu optical technology as "synchronized with the market", and the target price was reduced by 21.6% to HK $200.
The Hong Kong Stock Exchange (00388) was sold a net HK $164 million. On the news front, Citigroup released a research report, reiterating the "sell" rating of the HKEx. The IPO of the HKEx was mainly driven by the return of new economy stocks and China concept stocks. It had previously been estimated that the return of China concept stocks would increase the average daily turnover to 35 billion yuan. Considering that the average daily turnover was lower than expected, the earnings per share forecast for fiscal year 202224 was reduced by 5%, and the target price was reduced by 5% from HK $400 to HK $380.
In addition, China Construction Bank Corporation(601939) (00939) received a net purchase of HK $23.28 million. While Great Wall Motor Company Limited(601633) (02333), Tsingtao Brewery Company Limited(600600) shares (00168) and Dongyue Group (00189) were sold net of HK $258 million, HK $53.85 million and HK $14.52 million respectively.
